Aminopeptidasic Enzymes as Early Biomarkers of Cardiac Surgery-Associated Acute Kidney Injury and Long-Term Events
Biomolecules · 2024
DOI: 10.3390/biom14091049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Noelia Rísquez Chica und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Virgen de las Nieves University Hospital, FIBAO, Instituto de Investigación Biosanitaria ibs, 18014 Granada, Spain. Hauptthemen laut MEDLINE: Acute Kidney Injury, Biomarkers, Cardiac Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Carlos III Health Institute of Spain, Cooperative Research Network.
Abstract (Originalsprache)
Background
Diagnosis of acute kidney injury (AKI) relies on serum creatinine (SCr) changes. This study investigated if urinary aminopeptidases are early and predictive biomarkers of cardiac surgery-associated AKI (CSA-AKI).
Methods
Glutamyl aminopeptidase (GluAp), alanyl aminopeptidase (AlaAp), dipeptidyl peptidase-4 (DPP4), proteinuria, albuminuria, N-acetyl-β-D-glucosaminidase (NAG), and neutrophile gelatinase-associated lipocalin (NGAL) were measured in urine samples from 44 patients at arrival in the intensive care unit (ICU) after cardiac surgery. Sensitivity, specificity, and positive and negative predictive value for diagnosis of stages 1, 2, and 3 of AKI were analyzed for the highest quartile of each marker. We also studied the relationship with SCr after surgery, 6- and 12-month glomerular filtration rates (GFRs), and other long-term events over the next 5 years.
Results
GluAp diagnosed the maximal number of patients that developed stage 2 or 3 of AKI, increasing diagnostic sensitivity from 0% to 75%. In addition, GluAp and DPP4 were related to the decrease in GFR at 6 or 12 months after surgery.
Conclusions
Urinary aminopeptidases are a potential tool for the early diagnosis of CSA-AKI, with GluAp being the most effective marker for diagnosing stage 2 or 3 of AKI at ICU admission. GluAp and DPP4 serve as predictive biomarkers for a decrease in GFR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Unit, Virgen de las Nieves University Hospital, FIBAO, Instituto de Investigación Biosanitaria ibs, 18014 Granada, Spain.
- Intensive Care Unit, Virgen de las Nieves University Hospital, FIBAO, Instituto de Investigación Biosanitaria ibs, 18014 Granada, Spain.
- Area of Physiology, Department of Health Sciences, University of Jaén, 23071 Jaén, Spain.
ORCID-Profile: Rosemary Wangensteen
Förderung
- Instituto de Salud Carlos III
- Carlos III Health Institute of Spain
- Cooperative Research Network
Zitieren
APA
Rísquez Chica, N., Pereira, E., Manzano, F., Quintana, M. M. J., Osuna, A., Fuentes, M. C. R., & Wangensteen, R. (2024). Aminopeptidasic Enzymes as Early Biomarkers of Cardiac Surgery-Associated Acute Kidney Injury and Long-Term Events. Biomolecules. https://doi.org/10.3390/biom14091049
Vancouver
Rísquez Chica N, Pereira E, Manzano F, Quintana MMJ, Osuna A, Fuentes MCR, et al. Aminopeptidasic Enzymes as Early Biomarkers of Cardiac Surgery-Associated Acute Kidney Injury and Long-Term Events. Biomolecules. 2024. doi:10.3390/biom14091049
BibTeX
@article{RsquezChica2024,
author = {Rísquez Chica, Noelia and Pereira, Elisa and Manzano, Francisco and Quintana, María Mar Jiménez and Osuna, Antonio and Fuentes, María Carmen Ruiz and Wangensteen, Rosemary},
title = {Aminopeptidasic Enzymes as Early Biomarkers of Cardiac Surgery-Associated Acute Kidney Injury and Long-Term Events},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14091049}
}
EUVIMED